Hygeia Health Holdings Limited (Hygeia Health) submitted its disclosure report on September 2, 2024, disclosing the changes in issued shares or treasury shares. According to the Listing Rules of The Stock Exchange of Hong Kong Limited (HKEX), as of August 31, 2024, the company had 631,524,200 issued shares and 0 treasury shares. On September 2, 2024, Hygeia Health repurchased 1,997,200 ordinary shares, accounting for 0.3163% of the issued shares, with a repurchase price ranging from HKD 16.94 to HKD 19.38 per share, totaling HKD 36,428,112. The shares will be proposed for cancellation, and the repurchase activity was authorized by the shareholders' resolution on June 28, 2024. After the repurchase, the company will enter a one-month moratorium until October 2, 2024, during which no new share issuances or further sales or transfers of treasury shares are allowed.

Hygeia Health Holdings Limited (Hygeia Health) submitted its disclosure report on September 2, 2024, disclosing the changes in issued shares or treasury shares. According to the Listing Rules of The Stock Exchange of Hong Kong Limited (HKEX), as of August 31, 2024, the company had 631,524,200 issued shares and 0 treasury shares. On September 2, 2024, Hygeia Health repurchased 1,997,200 ordinary shares, accounting for 0.3163% of the issued shares, with a repurchase price ranging from HKD 16.94 to HKD 19.38 per share, totaling HKD 36,428,112. The shares will be proposed for cancellation, and the repurchase activity was authorized by the shareholders' resolution on June 28, 2024. After the repurchase, the company will enter a one-month moratorium until October 2, 2024, during which no new share issuances or further sales or transfers of treasury shares are allowed.